Geron Corporation (NASDAQ:GERN) is one of the best low priced pharma stocks to buy now. Earlier on May 28, Geron Corporation ...

Advances in blood stem cell transplants now make it possible for people with blood cancers to get safe and effective ...

The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for decitabine/cedazuridine plus venetoclax to treat adults with newly diagnosed acute myeloid leukemia ...

Dr. Mika Kontro, MD, PhD, will deliver a presentation titled "Efficacy of Macrophage Checkpoint Clever-1 Inhibition with ...

Ashwin Kishtagari, MD, of Vanderbilt University Medical Center in Nashville, summarizes 7 studies presented at the EHA 2025 Congress.

A UVA Cancer Center study shows that blood cancer patients who receive partially matched stem cell transplants have survival ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

The report provides a detailed analysis of the current myelodysplastic syndrome marketed drugs and late-stage pipeline drugs.

Pune: A 70-year-old woman from Mumbai, misdiagnosed with myelodysplastic syndromes (MDS), a type of blood cancer specifically ...

It took a misplaced elbow, a quirk of Los Angeles geography and some whistling from his wife to produce one of television’s most memorable melodies.